Wuhan Wuyao Pharmaceutical Co., Ltd., holding subsidiary of Grand Pharmaceutical (China) Co., Ltd., Is a hi-tech enterprise which engaged in the API productions and sales.The company mainly produces Analgin, Metronidazole, Enoxacin, Pirenoxine sodium APIs and their Intermediates. It has more than 40 products, with annual production capacity over 4,000 tons. Its products, Hydrochloric acid tirofiban and enoxacin, are national Second-class drugs. What's more, sodium pirenoxine and Adrenaline series are company's exclusive products in China.At present, it owns a strong professional and high-tech team, which developed 7 kinds of new drugs, such as lansoprazole, The company organizes production strictly in accordance with the GMP requirements. Most products have obtained the GMP certification. Noradrenaline Bitartrate have obtained the U.S. Food and Drug Administration (FDA) certification, metronidazole is approved With EU COS certification. In 2012, the company achieved the ISO quality management system certification.With the target of being world-renowned supplier of API and leader of domestic enterprises, the company increases investment in research, expands scale of generic drugs, accelerates market and sales, promotes team training, and sets up professional team and independent R & D Technology Center. The company achieves goal of exporting products by constructing FDA, EU certified plant, obtains CGMP and EUGMP certification, all these make it more specialized, technological and international!